World Meeting on Sexual Medicine - Helpful Links
Peyronie's Disease and Xiaflex
In time, the drug Xiaflex may become an FDA-approved treatment option for men with Peyronie's disease in the United States.
Peyronie's disease occurs when areas of hardened scar tissue called plaques form on the penis. The result is a curvature that can make intercourse difficult.
Auxilium Pharmaceuticals, the maker of Xiaflex, recently announced the results of its Phase III clinical trials of the drug. Two groups of approximately 400 men each participated.
The researchers found that the men who had injections of Xiaflex had greater reductions in curvature than the men who were given a placebo.
The men who took Xiaflex also reported less pain and fewer psychological and physical symptoms.
The manufacturer plans to apply for FDA approval for Xiaflex and the treatment of Peyronie's disease later this year. If approved, Xiaflex can be marketed for that purpose in the U.S.
To learn more about Xiaflex, how it works, its side effects, and the recent clinical trials, click here.